Jump to page content

Charité-Universitätsmedizin Berlin and the Israel Innovation Authority are launching an innovation and validation program in (digital) healthcare solutions. Israeli companies will have the chance to partner with Charité scientists and clinical researchers to validate, test, pilot and/or adapt their impactful innovative healthcare technologies, services and devices. With this call, Charité and Israel Innovation Authority are seeking to establish the cooperation between researchers with excellent clinical and scientific background at Charité and BIH and the huge innovative potential of Israeli companies to successfully advance translational science and ultimately patient care in German healthcare system and beyond.

Project applications may include joint R&D activities as well as clinical trial at every stage, pilot trials and validation activities. In the framework of the International Health-Tech Pilot Program, launched May, 13th by the IIA, interested companies are invited to submit their Expression of Interest to co-develop and/or validate their healthcare related technology and software solutions until July, 2nd 2020. In the second phase of the program (until September 2020), researchers at Charité and BIH will have the opportunity to partner with one of the start-up companies and together apply for project funding at the IIA.

We are excited about collaborating with one of the world’s leading countries in terms of innovation and start-up culture.

Dr. Sein Schmidt, Head of the BIH Clinical Research Unit at the Charité and coordinator of the Israel-project

Background and Program

  • Background

    Israel Innovation Authority and the cooperation with the Charité and BIH.

    Read more
  • Program

    Information on the Program, conditions of participation, selection process and application deadlines.

    Read more

Start-Ups and Agenda

Germany is Israel’s most important trading partner in the European Union.

H.E. Jeremy Issacharoff, Israel’s Ambassador in Germany

Project head

Dr. med. Sein Schmidt
Scientific and Medical Director, Clinical Trial Unit – Clinical Study Center (CSC), BIH, Charité

Partners

Contact persons

  • Dr. med. Sein Schmidt

    Scientific and Medical Director of the Clinical Trial Unit of the Clinical Study Center (CSC), BIH, Charité

  • Maria Rönnefahrt

    Project coordination of the cooperation in the Clinical Trial Unit of the Clinical Study Center (CSC), BIH, Charité

    Contact information
    Phone:+49 30 450 643 653
    E-mail:maria.moennefarth@charite.de
  • Luise Roither

    Strategic Co-operations Manager

    Contact information
    Phone:+49 30 450 543 025
    E-mail:luise.roither@bih-charite.de